Vermillion Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Sell
52
-7
-12% -$2.6K ﹤0.01% 912
2026
Q1
$17.4K Buy
59
+8
+16% +$2.63K 0.01% 316
2025
Q4
$17.9K Hold
51
0.01% 299
2025
Q3
$16.5K Hold
51
﹤0.01% 925
2025
Q2
$19.7K Buy
51
+1
+2% +$402 0.01% 263
2025
Q1
$21.9K Hold
50
0.01% 686
2024
Q4
$18.5K Buy
+50
New +$20.9K 0.01% 263

Other funds holding ELV

Vermillion Wealth Management's ELV Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Elevance Health (ELV) stake by 12% in Q2 2026, selling an estimated $2.6K and leaving 52 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Vermillion Wealth Management first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.9K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vermillion Wealth Management held 52 shares of Elevance Health worth $20K as of Q2 2026.
  • Vermillion Wealth Management sold 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
  • Elevance Health made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #912 holding.
  • Vermillion Wealth Management first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Elevance Health position peaked at $21.9K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.